Strategic Blueprint’s Hologic HOLX Stock Holding History

Strategic Blueprint’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8	Closed	-$1K	–	794
2021 Q2	$1K	Buy	+8	New	+$535	﹤0.01%	1317

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Strategic Blueprint's HOLX Position: Q3 2021 in Review

Strategic Blueprint sold out of Hologic (HOLX) in Q3 2021, closing a stake of 8 shares — an estimated $1K sold.

Strategic Blueprint first reported a position in HOLX in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 644 funds tracked by Wall St. Rank hold HOLX as of Q3 2021.

Strategic Blueprint reported no remaining Hologic position as of Q3 2021 after selling out during the quarter.
Strategic Blueprint sold 8 Hologic shares in Q3 2021, an estimated $1K.
Strategic Blueprint first reported a position in Hologic in Q2 2021 and held it in 1 quarter.
Strategic Blueprint's Hologic position peaked at $1K in Q2 2021.
644 funds tracked by Wall St. Rank held Hologic as of Q3 2021.

Based on Strategic Blueprint's 13F filing for Q3 2021, filed 12 Nov 2021.